BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33216264)

  • 1. Impact of Capicua on Pancreatic Cancer Progression.
    Yoshiya S; Itoh S; Yoshizumi T; Yugawa K; Kurihara T; Toshima T; Harada N; Hashisako M; Yonemasu H; Fukuzawa K; Oda Y; Mori M
    Ann Surg Oncol; 2021 Jun; 28(6):3198-3207. PubMed ID: 33216264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.
    Kim E; Kim D; Lee JS; Yoe J; Park J; Kim CJ; Jeong D; Kim S; Lee Y
    Hepatology; 2018 Jun; 67(6):2287-2301. PubMed ID: 29251790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capicua suppresses colorectal cancer progression via repression of ETV4 expression.
    Lee JS; Kim E; Lee J; Kim D; Kim H; Kim CJ; Kim S; Jeong D; Lee Y
    Cancer Cell Int; 2020; 20():42. PubMed ID: 32042269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
    Yan J; Jia Y; Chen H; Chen W; Zhou X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor.
    Zhou Y; Wang M; Shuang T; Liu Y; Zhang Y; Shi C
    Pathol Res Pract; 2019 Oct; 215(10):152606. PubMed ID: 31500928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression.
    Choi N; Park J; Lee JS; Yoe J; Park GY; Kim E; Jeon H; Cho YM; Roh TY; Lee Y
    Oncotarget; 2015 Sep; 6(27):23533-47. PubMed ID: 26124181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
    Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
    Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
    Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
    Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.
    Weissmann S; Cloos PA; Sidoli S; Jensen ON; Pollard S; Helin K
    Cancer Res; 2018 Aug; 78(15):4114-4125. PubMed ID: 29844126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making heads or tails - the emergence of capicua (CIC) as an important multifunctional tumour suppressor.
    Wong D; Yip S
    J Pathol; 2020 Apr; 250(5):532-540. PubMed ID: 32073140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer.
    Kim JW; Luck C; Wu W; Ponce RK; Lin YK; Gupta N; Okimoto RA
    Cell Rep; 2022 Oct; 41(1):111443. PubMed ID: 36198276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.
    Simón-Carrasco L; Jiménez G; Barbacid M; Drosten M
    Cell Cycle; 2018; 17(6):702-711. PubMed ID: 29578365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
    Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
    Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressing PRMT1 Inhibits Proliferation and Invasion in Pancreatic Cancer by Inverse Correlation of ZEB1.
    Lin Z; Chen Y; Lin Z; Chen C; Dong Y
    IUBMB Life; 2018 Oct; 70(10):1032-1039. PubMed ID: 30194893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
    Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
    Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors.
    Ahmad ST; Rogers AD; Chen MJ; Dixit R; Adnani L; Frankiw LS; Lawn SO; Blough MD; Alshehri M; Wu W; Marra MA; Robbins SM; Cairncross JG; Schuurmans C; Chan JA
    Nat Commun; 2019 May; 10(1):2000. PubMed ID: 31043608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capicua restricts cancer stem cell-like properties in breast cancer cells.
    Yoe J; Kim D; Kim S; Lee Y
    Oncogene; 2020 Apr; 39(17):3489-3506. PubMed ID: 32108163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
    Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.